Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis.

Journal for immunotherapy of cancer·2022
Same author

Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia.

Open forum infectious diseases·2020
Same author

Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma.

Journal of fungi (Basel, Switzerland)·2019
Same author

Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.

Human vaccines & immunotherapeutics·2016
Same author

Type-specific clinical characteristics of adenovirus-associated influenza-like illness at five US military medical centers, 2009-2014.

Influenza and other respiratory viruses·2016
Same author

Changing Susceptibility of Staphylococcus aureus in a US Pediatric Population.

Pediatrics·2016
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumocystis pneumonia.

Laurie C D'Avignon1, Christina M Schofield, Duane R Hospenthal

  • 1Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, Texas 78234, USA. laurie.davignon@amedd.army.mil

Seminars in Respiratory and Critical Care Medicine
|March 28, 2008
PubMed
Summary
This summary is machine-generated.

Pneumocystis pneumonia (PCP) remains a significant threat to immunocompromised individuals, including those with acquired immunodeficiency syndrome (AIDS). Continued research into this opportunistic fungal infection is crucial due to its persistent mortality rates and increasing incidence in diverse immunosuppressed populations.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Pneumocystis is an opportunistic fungus causing significant morbidity and mortality in immunocompromised individuals.
  • Despite advances like highly active antiretroviral therapy (HAART), Pneumocystis pneumonia (PCP) remains common in acquired immunodeficiency syndrome (AIDS) patients.
  • PCP is increasingly recognized in non-AIDS immunosuppressed populations, with potentially higher mortality rates.

Purpose of the Study:

  • To highlight the ongoing significance of Pneumocystis infections.
  • To underscore the need for continued evaluation of PCP's epidemiology, diagnosis, and treatment.
  • To address the increasing incidence and severity of PCP in various immunosuppressed groups.

Main Methods:

  • Review of existing literature on Pneumocystis infections.
  • Analysis of incidence and mortality data in AIDS and non-AIDS immunosuppressed patients.
  • Examination of evidence regarding potential reservoirs in normal hosts.

Main Results:

  • Pneumocystis remains a leading opportunistic infection in AIDS patients, with 10-20% mortality.
  • PCP incidence is rising in non-AIDS immunosuppressed populations.
  • Mortality data for non-AIDS patients with PCP is poorly defined but potentially high.

Conclusions:

  • Pneumocystis pneumonia necessitates ongoing investigation due to its persistent severity and expanding impact.
  • Further research is vital for understanding PCP epidemiology, clinical presentation, diagnosis, and treatment across all immunosuppressed groups.
  • The role of normal hosts as reservoirs requires further exploration.